HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Judith Naud Selected Research

1-hydroxymethylmidazolam

10/2009ESRD impairs nonrenal clearance of fexofenadine but not midazolam.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Judith Naud Research Topics

Disease

8Chronic Kidney Failure (Chronic Renal Failure)
08/2011 - 12/2002
3Kidney Diseases (Kidney Disease)
01/2015 - 10/2009
3Uremia
09/2010 - 10/2008
1Breast Neoplasms (Breast Cancer)
01/2012

Drug/Important Bio-Agent (IBA)

7Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
08/2011 - 12/2002
3EnzymesIBA
01/2015 - 10/2009
1OxidoreductasesIBA
01/2015
1Organic Anion TransportersIBA
01/2012
1Messenger RNA (mRNA)IBA
01/2012
1P-GlycoproteinIBA
01/2012
1Protein Isoforms (Isoforms)IBA
09/2010
1Calcifediol (Calcidiol)FDA Link
09/2010
1Proteins (Proteins, Gene)IBA
10/2009
1Cytochrome P-450 CYP3AIBA
10/2009
1Midazolam (Versed)FDA LinkGeneric
10/2009
1fexofenadine (Allegra)FDA LinkGeneric
10/2009
11-hydroxymethylmidazolamIBA
10/2009
1NF-kappa B (NF-kB)IBA
10/2008
1andrographolideIBA
10/2008
1Parathyroid Hormone (Parathormone)IBA
11/2006

Therapy/Procedure

1Parathyroidectomy
09/2010
1Oral Administration
10/2009
1Renal Dialysis (Hemodialysis)
10/2008
1Transplantation (Transplant Recipients)
10/2008